Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6551
DELISTED
United Security Bancshares
UBFO
| – | – |
-28
| Closed | – | – |
|
6552
Urban One Class A
UONE
$18.7M
| $0 | ﹤0.01% |
1
| – | – |
2013 Q4
6 quarters
|
|
6553
US Gold Corp
USAU
$228M
| – | – |
0
| – | – |
2014 Q3
3 quarters
|
|
6554
UTStarcom
UTSI
$21.5M
| $0 | ﹤0.01% |
20
| – | – |
2013 Q2
8 quarters
|
|
6555
Virco
VIRC
$102M
| $0 | ﹤0.01% |
26
-44
| -63% | -$118 |
2013 Q4
6 quarters
|
|
6556
Viking Therapeutics
VKTX
$3.63B
| $0 | ﹤0.01% |
+16
| New | +$132 |
2015 Q2
0 quarters
|
|
6557
Viridian Therapeutics
VRDN
$2.11B
| – | – |
0
| – | – |
2014 Q3
3 quarters
|
|
6558
DELISTED
G. Willi-Food International
WILC
| $0 | ﹤0.01% |
+23
| New | +$129 |
2015 Q2
0 quarters
|
|
6559
Western Copper and Gold
WRN
$475M
| $0 | ﹤0.01% |
757
| – | – |
2013 Q4
6 quarters
|
|
6560
XTL Biopharmaceuticals
XTLB
$4.87M
| – | – |
0
| – | – |
2014 Q1
5 quarters
|
|
6561
Xtant Medical Holdings
XTNT
$45.7M
| – | – |
-472
| Closed | -$23K | – |
|
6562
Direxion Daily FTSE China Bear 3X ETF
YANG
$110M
| – | – |
0
| – | -$1K |
2013 Q4
6 quarters
|
|
6563
Yunhong Green CTI Ltd
YHGJ
$7.18M
| $0 | ﹤0.01% |
1
| – | – |
2014 Q1
5 quarters
|
|
6564
XTI Aerospace
XTIA
$34.9M
| – | – |
0
| – | – |
2014 Q2
4 quarters
|
|
6565
AI Financial Corp
AIFC
$61M
| $0 | ﹤0.01% |
2
| – | – |
2013 Q4
6 quarters
|
|
6566
Q/C Technologies Inc
QCLS
$5.16M
| – | – |
0
| – | – |
2014 Q1
5 quarters
|
|
6567
Oruka Therapeutics
ORKA
$5.44B
| – | – |
0
| – | – |
2014 Q3
3 quarters
|
|
6568
Grace Therapeutics
GRCE
$43.8M
| – | – |
0
| – | – |
2014 Q1
5 quarters
|
|
6569
JX Luxventure
JXG
$86.2M
| – | – |
0
| – | – |
2015 Q2
0 quarters
|
|
6570
Ridgetech Inc
RDGT
$3.67M
| – | – |
0
| – | – |
2014 Q1
5 quarters
|
|
6571
VisionSys AI
VSA
$5.42M
| – | – |
-56
| Closed | -$1.37M | – |
|
6572
Tecogen Inc
TGEN
$73.1M
| $0 | ﹤0.01% |
28
+1
| +4% | +$5 |
2014 Q2
4 quarters
|
|
6573
DELISTED
Wilhelmina International, Inc
WHLM
| $0 | ﹤0.01% |
26
+1
| +4% | +$5 |
2014 Q3
3 quarters
|
|
6574
DELISTED
Golden Minerals Company
AUMN
| – | – |
-16
| Closed | – | – |
|
6575
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| – | – |
-169
| Closed | -$31K | – |
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.